Executive Summary Rare disease assessments rely on specialist clinical and patient expertise to inte...
Read moreAs NICE and EU Joint Clinical Assessment (JCA) requirements increasingly need to be considered in pa...
Read moreThe first EU Joint Clinical Assessment (JCA) has now been published, providing the first practical i...
Read moreExpert contributions are critical to health technology assessment (HTA), particularly in rare diseas...
Read moreThe HTA Coordination Group (HTACG) has now confirmed the 2026 request periods for joint scientific c...
Read moreObjectives: EUHTA regulation has applied from the 1st January 2025 for oncology pr...
Read moreObjectives: To analyse how the mandatory EU Joint Clinical Assessment (JCA) could in...
Read moreFive success pillars — your JCA evidence-generation checklist From 12th January 2025, the Eu...
Read moreThe Joint Clinical Assessment (JCA), a core feature of the Regulation (EU) 2021/2282, aims to stream...
Read moreRemap Consulting presents ground-breaking insights and practical learnings from one of the pioneerin...
Read more